A truly creative attempt at a diversion, but it fails.
There is no obvious linkage to the FDA request for data on those most at risk in the placebo group and who benefited the most in the treatment group, how do you tie that in to your tactic, into the echoes.
Cell Therapy News/Articles, page-13477
-
- There are more pages in this discussion • 4,769 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.335B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1981 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 812 | 1 |
View Market Depth
| Last trade - 09.46am 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable